{"title":"Novedades en colitis ulcerosa: a propósito de la aprobación en México de un nuevo mecanismo de acción anti-interleucinas 12 y 23 (ustekinumab)","authors":"Francisca Martínez-Silva","doi":"10.24875/imids.m22000026","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":424172,"journal":{"name":"Revista mexicana de enfermedades inflamatorias inmunomediadas","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista mexicana de enfermedades inflamatorias inmunomediadas","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24875/imids.m22000026","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}